A Multicenter Phase 3 Randomized, Open-Label Study of Bosutinib versus Imatinib in Adult Patients with Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia - Regional Cancer Care Associates LLC

Clinical Trials

A Multicenter Phase 3 Randomized, Open-Label Study of Bosutinib versus Imatinib in Adult Patients with Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Type of Cancer
Leukemia
Locations
Bethesda
Sponsor
Protocol Number
AV001
Cancer Diagnosis
To Learn More Call
201-510-0910